OA09037A - Prevention and treatement of retroviral disease. - Google Patents
Prevention and treatement of retroviral disease.Info
- Publication number
- OA09037A OA09037A OA59525A OA59525A OA09037A OA 09037 A OA09037 A OA 09037A OA 59525 A OA59525 A OA 59525A OA 59525 A OA59525 A OA 59525A OA 09037 A OA09037 A OA 09037A
- Authority
- OA
- OAPI
- Prior art keywords
- immunogen
- retrovirus
- hiv
- infectious
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3687—Chemical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6028087A | 1987-06-10 | 1987-06-10 | |
| US20075288A | 1988-05-31 | 1988-05-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA09037A true OA09037A (en) | 1991-03-31 |
Family
ID=26739775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA59525A OA09037A (en) | 1987-06-10 | 1989-02-10 | Prevention and treatement of retroviral disease. |
Country Status (14)
| Country | Link |
|---|---|
| EP (3) | EP0317622B1 (xx) |
| JP (1) | JPH0720880B2 (xx) |
| AT (1) | ATE132374T1 (xx) |
| AU (1) | AU612383B2 (xx) |
| CA (1) | CA1336407C (xx) |
| DE (1) | DE3854857T2 (xx) |
| DK (1) | DK56389A (xx) |
| FI (1) | FI95871C (xx) |
| IL (1) | IL86675A (xx) |
| NO (1) | NO175846C (xx) |
| OA (1) | OA09037A (xx) |
| RU (1) | RU2111010C1 (xx) |
| UA (1) | UA27716C2 (xx) |
| WO (1) | WO1988009670A1 (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU620804B2 (en) * | 1987-03-23 | 1992-02-27 | Hiver Limited | Novel vaccines |
| US5256767A (en) * | 1987-06-10 | 1993-10-26 | The Immune Response Corporation | Retroviral antigens |
| US5227159A (en) * | 1989-01-31 | 1993-07-13 | Miller Richard A | Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies |
| WO1990015133A1 (en) * | 1989-05-30 | 1990-12-13 | Nippon Zeon Co., Ltd. | Method of producing core structure of retro virus and particle produced thereby |
| FR2661834B1 (fr) * | 1990-05-09 | 1995-01-27 | Merieux Inst | Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus. |
| AU4685293A (en) * | 1992-07-20 | 1994-02-14 | Immune Response Corporation, The | Prophylactic and therapeutic control of retroviral infections |
| ATE189697T1 (de) * | 1994-03-22 | 2000-02-15 | Immune Response Corp Inc | Die hocheffiziente herstellung und isolierung von viruspartikeln |
| IT1271593B (it) * | 1994-11-30 | 1997-06-04 | Sanitaria Scaligera Spa | Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4716102A (en) * | 1984-08-15 | 1987-12-29 | Regents Of The University Of California | Purified AIDS-associated virus ARV-2 |
| DK507185A (da) * | 1984-11-05 | 1986-05-06 | Du Pont | Fremgangsmaade til inaktivering af human tumor leukaemi virus iii |
| US4725669A (en) * | 1984-11-09 | 1988-02-16 | President And Fellows Of Harvard College | Assay for detecting infection by human T-cell lymphotropic virus-III |
| ATE138100T1 (de) * | 1984-12-24 | 1996-06-15 | Genentech Inc | Fusionen von aids-verwandten polypeptiden |
| ES8706824A1 (es) * | 1985-04-08 | 1987-07-01 | Genetic Systems Corp | Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia. |
| NZ215867A (en) * | 1985-04-19 | 1989-10-27 | Hoffmann La Roche | Aids envelope protein, dna vectors and method of production |
| WO1987002892A1 (en) * | 1985-11-14 | 1987-05-21 | President And Fellows Of Harvard College | T-lymphotrophic virus |
| EP0250128A3 (en) * | 1986-06-18 | 1988-06-08 | American Registry of Pathology | Novel virus isolated from patients with aids |
| WO1988007058A1 (en) * | 1987-03-16 | 1988-09-22 | Biosolutions Pty. Ltd. | Anti-paratopic antibody as an immunogen |
-
1988
- 1988-06-09 AT AT88906347T patent/ATE132374T1/de not_active IP Right Cessation
- 1988-06-09 RU SU5052305A patent/RU2111010C1/ru not_active IP Right Cessation
- 1988-06-09 EP EP88906347A patent/EP0317622B1/en not_active Expired - Lifetime
- 1988-06-09 EP EP93250368A patent/EP0602761A1/en not_active Withdrawn
- 1988-06-09 EP EP95250152A patent/EP0685236A1/en not_active Withdrawn
- 1988-06-09 UA UA5052305A patent/UA27716C2/uk unknown
- 1988-06-09 WO PCT/US1988/001955 patent/WO1988009670A1/en active IP Right Grant
- 1988-06-09 CA CA000569026A patent/CA1336407C/en not_active Expired - Fee Related
- 1988-06-09 DE DE3854857T patent/DE3854857T2/de not_active Expired - Fee Related
- 1988-06-09 IL IL86675A patent/IL86675A/xx not_active IP Right Cessation
- 1988-06-09 AU AU19626/88A patent/AU612383B2/en not_active Ceased
- 1988-06-09 JP JP63505484A patent/JPH0720880B2/ja not_active Expired - Fee Related
-
1989
- 1989-02-08 DK DK056389A patent/DK56389A/da not_active Application Discontinuation
- 1989-02-08 FI FI890603A patent/FI95871C/fi not_active IP Right Cessation
- 1989-02-09 NO NO890565A patent/NO175846C/no unknown
- 1989-02-10 OA OA59525A patent/OA09037A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK56389D0 (da) | 1989-02-08 |
| EP0317622A4 (en) | 1990-05-14 |
| UA27716C2 (uk) | 2000-10-16 |
| FI890603A0 (fi) | 1989-02-08 |
| EP0317622A1 (en) | 1989-05-31 |
| JPH0720880B2 (ja) | 1995-03-08 |
| FI95871B (fi) | 1995-12-29 |
| JPH02500440A (ja) | 1990-02-15 |
| EP0317622B1 (en) | 1996-01-03 |
| EP0602761A1 (en) | 1994-06-22 |
| IL86675A (en) | 1993-04-04 |
| NO890565D0 (no) | 1989-02-09 |
| ATE132374T1 (de) | 1996-01-15 |
| AU1962688A (en) | 1989-01-04 |
| NO175846C (no) | 1994-12-21 |
| DE3854857T2 (de) | 1996-08-22 |
| CA1336407C (en) | 1995-07-25 |
| NO890565L (no) | 1989-02-09 |
| AU612383B2 (en) | 1991-07-11 |
| NO175846B (xx) | 1994-09-12 |
| RU2111010C1 (ru) | 1998-05-20 |
| FI890603A (fi) | 1989-02-08 |
| FI95871C (fi) | 1996-04-10 |
| DE3854857D1 (de) | 1996-02-15 |
| DK56389A (da) | 1989-02-08 |
| WO1988009670A1 (en) | 1988-12-15 |
| EP0685236A1 (en) | 1995-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU94042386A (ru) | Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита | |
| ATE144143T1 (de) | Künstlicher impfstoff gegen aids-virus | |
| DK1276896T3 (da) | Epitop-synkronisering i antigen-præsenterende celler | |
| HUP9801560A1 (hu) | Szaponint és szterint tartalmazó vakcinák | |
| DE69426077D1 (de) | Adjuvantien für impfstoffe gegen das respiratorische synzitialvirus | |
| EP0330359A3 (en) | Composition useful in the diagnosis and treating of hiv-1 infection | |
| ATE418562T1 (de) | Ctl epitope des epstein-barr virus | |
| ATE331026T1 (de) | Antigen-markierte nicht-infektiöse retrovirus- ähnlige partikel | |
| EP0232798A3 (en) | Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same | |
| EP1375511A3 (en) | Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus | |
| OA09037A (en) | Prevention and treatement of retroviral disease. | |
| ATE284709T1 (de) | Virale chimären aus caev und hiv-1 genetischen elementen | |
| HK1021133A1 (en) | Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection | |
| EP0309898A3 (en) | Method for the induction of a cytotoxic t cell response | |
| HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
| IT1233419B (it) | Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria | |
| Zourbas et al. | Immunization of dental surgeons against hepatitis B virus infection. | |
| WO1991008771A3 (fr) | Procede de culture intensive, in vitro, de souches de babesia divergens, procede de preparation d'exoantigenes et vaccin contenant ces antigenes | |
| CA2249736A1 (en) | Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection | |
| AU6791290A (en) | Antigens relating to envelope glyoprotein of the virus of aids, particularly precursors of this glycoprotein, methods of obtaining these antigens and means employed in these methods, applications of these antigens in the preparation of immunogenic compositions or for the diagnosis of aids or | |
| SU1739559A1 (ru) | Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов |